•
PT
PTCT
PTC Therapeutics, Inc.
yahooPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
6.07B
Volume
1.18M
52W High
$87.50
52W Low
$35.95
Open
$0.00
Prev Close
$73.07
Day Range
0.00 - 0.00
About PTC Therapeutics, Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
Latest News
What's Going On With Royalty Pharma Stock Wednesday?
Benzinga•Dec 31
Royalty Pharma Acquires Remaining Royalty Interest in Roche's Evrysdi for $240 Million and Potential Milestones
Benzinga•Dec 29
Here's Why Shares in PTC Therapeutics Soared This Week
The Motley Fool•Sep 5
Novartis reports strong Q2 with double-digit sales growth and core margin expansion; raises FY 2025 core operating income guidance
GlobeNewswire Inc.•Jul 17
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR
GlobeNewswire Inc.•Jun 2
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
GlobeNewswire Inc.•Jun 2
RNA Targeting Small Molecule Drug Discovery Research Report 2025 - Global $5.52 Bn Market Trends, Opportunities, and Forecasts, 2020-2030F
GlobeNewswire Inc.•May 29
Evolving Landscape of Mitochondrial Disease Market: Key Insights of Latest Published Report—Leigh Syndrome, Leber’s Hereditary Optic Neuropathy, MELAS Syndrome, and Thymidine Kinase 2 Deficiency | DelveInsight
GlobeNewswire Inc.•May 26